WISeKey International Holding Ltd Secures CHF3 Million of Cash in a First Tranche of a Mandatory Convertible Loan Note Placed with Selected Strategic Investors
R-Biopharm AG and Gold Standard Diagnostics, Corp. Announce Strategic Alliance:
Condeco Raises $30m to Power New Era of Workplace Tech
New Data for KEYTRUDA® (pembrolizumab) in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at 2016 ASCO Annual Meeting
New Data from Phase 2 Study Evaluating KEYTRUDA® (pembrolizumab) for the Treatment of Cancers Deficient in DNA Mismatch Repair Show Durable Responses Across a Range of Cancers
New KEYTRUDA® (pembrolizumab) Data from KEYNOTE-010 and KEYNOTE-001 in Advanced Non-Small Cell Lung Cancer, Including Survival Data, To Be Presented at 2016 ASCO Annual Meeting
Jones Lang LaSalle should be able to weather upcoming merger of smaller peers.
Though both are preferable to accumulating cash, paying dividends is a better method for preserving shareholder value, says Morningstar's Matt Coffina.
Plus, our take on the prospects for Canadian energy, where insufficient pipeline capacity is limiting access to export markets.
China's expanding middle class will give e-commerce a boost.